Copyright Reports & Markets. All rights reserved.

Global Hematopoietic Stem Cells Transplantation Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Hematopoietic Stem Cells Transplantation by Type
    • 1.3.1 Overview: Global Hematopoietic Stem Cells Transplantation Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Type in 2025
    • 1.3.3 Stem Cells Storage
    • 1.3.4 Stem Cells Consumables
  • 1.4 Global Hematopoietic Stem Cells Transplantation Market by Application
    • 1.4.1 Overview: Global Hematopoietic Stem Cells Transplantation Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Leukemia
    • 1.4.3 Lymphoproliferative Disorders
    • 1.4.4 Solid Tumors
    • 1.4.5 Non-Malignant Disorders
  • 1.5 Global Hematopoietic Stem Cells Transplantation Market Size & Forecast
  • 1.6 Global Hematopoietic Stem Cells Transplantation Market Size and Forecast by Region
    • 1.6.1 Global Hematopoietic Stem Cells Transplantation Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Hematopoietic Stem Cells Transplantation Market Size by Region, (2021-2032)
    • 1.6.3 North America Hematopoietic Stem Cells Transplantation Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Hematopoietic Stem Cells Transplantation Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size and Prospect (2021-2032)
    • 1.6.6 South America Hematopoietic Stem Cells Transplantation Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 CBR Systems
    • 2.1.1 CBR Systems Details
    • 2.1.2 CBR Systems Major Business
    • 2.1.3 CBR Systems Hematopoietic Stem Cells Transplantation Product and Solutions
    • 2.1.4 CBR Systems Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 CBR Systems Recent Developments and Future Plans
  • 2.2 China Cord Blood Corporation
    • 2.2.1 China Cord Blood Corporation Details
    • 2.2.2 China Cord Blood Corporation Major Business
    • 2.2.3 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product and Solutions
    • 2.2.4 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 China Cord Blood Corporation Recent Developments and Future Plans
  • 2.3 ViaCord
    • 2.3.1 ViaCord Details
    • 2.3.2 ViaCord Major Business
    • 2.3.3 ViaCord Hematopoietic Stem Cells Transplantation Product and Solutions
    • 2.3.4 ViaCord Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 ViaCord Recent Developments and Future Plans
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product and Solutions
    • 2.4.4 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.5 STEMCELL Technologies
    • 2.5.1 STEMCELL Technologies Details
    • 2.5.2 STEMCELL Technologies Major Business
    • 2.5.3 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product and Solutions
    • 2.5.4 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 STEMCELL Technologies Recent Developments and Future Plans
  • 2.6 Vcanbio
    • 2.6.1 Vcanbio Details
    • 2.6.2 Vcanbio Major Business
    • 2.6.3 Vcanbio Hematopoietic Stem Cells Transplantation Product and Solutions
    • 2.6.4 Vcanbio Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Vcanbio Recent Developments and Future Plans
  • 2.7 Merck Millipore
    • 2.7.1 Merck Millipore Details
    • 2.7.2 Merck Millipore Major Business
    • 2.7.3 Merck Millipore Hematopoietic Stem Cells Transplantation Product and Solutions
    • 2.7.4 Merck Millipore Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Merck Millipore Recent Developments and Future Plans
  • 2.8 Lonza Group
    • 2.8.1 Lonza Group Details
    • 2.8.2 Lonza Group Major Business
    • 2.8.3 Lonza Group Hematopoietic Stem Cells Transplantation Product and Solutions
    • 2.8.4 Lonza Group Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Lonza Group Recent Developments and Future Plans
  • 2.9 CellGenix Technologie Transfer
    • 2.9.1 CellGenix Technologie Transfer Details
    • 2.9.2 CellGenix Technologie Transfer Major Business
    • 2.9.3 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product and Solutions
    • 2.9.4 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CellGenix Technologie Transfer Recent Developments and Future Plans
  • 2.10 ThermoGenesis
    • 2.10.1 ThermoGenesis Details
    • 2.10.2 ThermoGenesis Major Business
    • 2.10.3 ThermoGenesis Hematopoietic Stem Cells Transplantation Product and Solutions
    • 2.10.4 ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 ThermoGenesis Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Hematopoietic Stem Cells Transplantation Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Hematopoietic Stem Cells Transplantation by Company Revenue
    • 3.2.2 Top 3 Hematopoietic Stem Cells Transplantation Players Market Share in 2025
    • 3.2.3 Top 6 Hematopoietic Stem Cells Transplantation Players Market Share in 2025
  • 3.3 Hematopoietic Stem Cells Transplantation Market: Overall Company Footprint Analysis
    • 3.3.1 Hematopoietic Stem Cells Transplantation Market: Region Footprint
    • 3.3.2 Hematopoietic Stem Cells Transplantation Market: Company Product Type Footprint
    • 3.3.3 Hematopoietic Stem Cells Transplantation Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Hematopoietic Stem Cells Transplantation Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Hematopoietic Stem Cells Transplantation Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Hematopoietic Stem Cells Transplantation Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Hematopoietic Stem Cells Transplantation Consumption Value by Type (2021-2032)
  • 6.2 North America Hematopoietic Stem Cells Transplantation Market Size by Application (2021-2032)
  • 6.3 North America Hematopoietic Stem Cells Transplantation Market Size by Country
    • 6.3.1 North America Hematopoietic Stem Cells Transplantation Consumption Value by Country (2021-2032)
    • 6.3.2 United States Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Hematopoietic Stem Cells Transplantation Consumption Value by Type (2021-2032)
  • 7.2 Europe Hematopoietic Stem Cells Transplantation Consumption Value by Application (2021-2032)
  • 7.3 Europe Hematopoietic Stem Cells Transplantation Market Size by Country
    • 7.3.1 Europe Hematopoietic Stem Cells Transplantation Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 7.3.3 France Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size by Region
    • 8.3.1 Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Region (2021-2032)
    • 8.3.2 China Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 8.3.5 India Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Hematopoietic Stem Cells Transplantation Consumption Value by Type (2021-2032)
  • 9.2 South America Hematopoietic Stem Cells Transplantation Consumption Value by Application (2021-2032)
  • 9.3 South America Hematopoietic Stem Cells Transplantation Market Size by Country
    • 9.3.1 South America Hematopoietic Stem Cells Transplantation Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country
    • 10.3.1 Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Hematopoietic Stem Cells Transplantation Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Hematopoietic Stem Cells Transplantation Market Drivers
  • 11.2 Hematopoietic Stem Cells Transplantation Market Restraints
  • 11.3 Hematopoietic Stem Cells Transplantation Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Hematopoietic Stem Cells Transplantation Industry Chain
  • 12.2 Hematopoietic Stem Cells Transplantation Upstream Analysis
  • 12.3 Hematopoietic Stem Cells Transplantation Midstream Analysis
  • 12.4 Hematopoietic Stem Cells Transplantation Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hematopoietic Stem Cells Transplantation market size was valued at US$ 2919 million in 2025 and is forecast to a readjusted size of US$ 4247 million by 2032 with a CAGR of 5.6% during review period.
    Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
    Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.
    This report is a detailed and comprehensive analysis for global Hematopoietic Stem Cells Transplantation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hematopoietic Stem Cells Transplantation market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Hematopoietic Stem Cells Transplantation market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Hematopoietic Stem Cells Transplantation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Hematopoietic Stem Cells Transplantation market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hematopoietic Stem Cells Transplantation
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hematopoietic Stem Cells Transplantation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies, Vcanbio, Merck Millipore, Lonza Group, CellGenix Technologie Transfer, ThermoGenesis, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Hematopoietic Stem Cells Transplantation market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Stem Cells Storage
    Stem Cells Consumables
    Market segment by Application
    Leukemia
    Lymphoproliferative Disorders
    Solid Tumors
    Non-Malignant Disorders
    Market segment by players, this report covers
    CBR Systems
    China Cord Blood Corporation
    ViaCord
    Thermo Fisher Scientific
    STEMCELL Technologies
    Vcanbio
    Merck Millipore
    Lonza Group
    CellGenix Technologie Transfer
    ThermoGenesis
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Hematopoietic Stem Cells Transplantation product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Hematopoietic Stem Cells Transplantation, with revenue, gross margin, and global market share of Hematopoietic Stem Cells Transplantation from 2021 to 2026.
    Chapter 3, the Hematopoietic Stem Cells Transplantation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Hematopoietic Stem Cells Transplantation market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Hematopoietic Stem Cells Transplantation.
    Chapter 13, to describe Hematopoietic Stem Cells Transplantation research findings and conclusion.

    Buy now